61 – 70 of 692
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity
- Contribution to journal › Article
-
Mark
Evolutionary unpredictability in cancer model systems
- Contribution to journal › Article
-
Mark
pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy
- Contribution to journal › Article
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma : a case report
- Contribution to journal › Article
- 2024
-
Mark
Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
- Contribution to journal › Scientific review
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
- Contribution to journal › Letter
-
Mark
Therapeutic potential of miR-379 in prostate cancer
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
- Contribution to journal › Article
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
- Contribution to journal › Article
